BRAFV600E Mutation Enhances Estrogen-Induced Metastatic Potential of Thyroid Cancer by Regulating the Expression of Estrogen Receptors.

Authors:
Kim M; Kim SJ; Ha SY; Xu Z; Han Y and 4 more

Journal:
Endocrinol Metab (Seoul)

Publication Year: 2022

DOI:
10.3803/EnM.2022.1563

PMCID:
PMC9816508

PMID:
36604958

Journal Information

Full Title: Endocrinol Metab (Seoul)

Abbreviation: Endocrinol Metab (Seoul)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported."

Evidence found in paper:

"This study was funded by the the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (Grant number: 2018R1C1B5045216), and the Seoul National University Hospital (SNUH) Research Fund (Grant No. 03- 2017-0190). We also acknowledge the support of the American Thyroid Association (ATA) and the Korean Cancer Association in the form of and 2018 ATA Trainee Grant and Merit Award, respectively."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025